RxDoctor Payments Data

Jose Cilliani, DO

Family Medicine · Santa Ana, CANPI 1265545586

Payments from drug & device makers

$345in general payments, 2019–2025

Across 20 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$103
  • Lilly USA, LLC$97
  • Novo Nordisk$47
  • GSK$33
  • Genentech USA, Inc.$30
  • Otsuka America Pharmaceutical, Inc.$20
  • plus $15 from 1 others

What the payments were for

  • Food & beverage$345100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$345 in reported general payments places this provider in the 55th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$37,887
Medicare patients
85
Services billed
364

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin47$61,222
JanuviaSitagliptin Phosphate47$57,986
EliquisApixaban23$33,977
TrulicityDulaglutide26$33,521
FarxigaDapagliflozin Propanediol25$31,131
Soliqua 100-33Insulin Glargine/Lixisenatide14$13,954
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$9,602
Lantus SolostarInsulin Glargine,hum.Rec.Anlog67$7,834
Atorvastatin Calcium819$7,050
AlogliptinAlogliptin Benzoate14$5,043
Metformin Hcl731$4,613
Pioglitazone Hcl252$3,956
Losartan Potassium374$3,197
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$3,169
Potassium Chloride147$3,160

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$97$33,52126 claims
AstraZenecaFarxiga$103$31,13125 claims
GSKTrelegy Ellipta$33$9,60215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 10,533 family medicine providers in California.

Other family medicine in Santa Ana

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →